Co-Diagnostics, Inc. (CODX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $622.5K | -84.1% |
| 2024 | $3.92M | -42.5% |
| 2023 | $6.81M | -80.1% |
| 2022 | $34.22M | -65.0% |
| 2021 | $97.89M | +31.3% |
| 2020 | $74.55M | +34579.9% |
| 2019 | $215.0K | +438.6% |
| 2018 | $39.9K | +420.9% |
| 2017 | $7.7K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $622.5K | -84.1% |
| 2024 | $3.92M | -42.5% |
| 2023 | $6.81M | -80.1% |
| 2022 | $34.22M | -65.0% |
| 2021 | $97.89M | +31.3% |
| 2020 | $74.55M | +34579.9% |
| 2019 | $215.0K | +438.6% |
| 2018 | $39.9K | +420.9% |
| 2017 | $7.7K | — |